Approved indication: chronic kidney disease associated with type 2 diabetes with albuminuria

被引:1
作者
不详
机构
关键词
FINERENONE;
D O I
10.18773/austprescr.2023.017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页数:26
相关论文
共 8 条
[1]   Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine [J].
Agarwal, Rajiv ;
Kolkhof, Peter ;
Bakris, George ;
Bauersachs, Johann ;
Haller, Hermann ;
Wada, Takashi ;
Zannad, Faiez .
EUROPEAN HEART JOURNAL, 2021, 42 (02) :152-161
[2]   Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis [J].
Agarwal, Rajiv ;
Filippatos, Gerasimos ;
Pitt, Bertram ;
Anker, Stefan D. ;
Rossing, Peter ;
Joseph, Amer ;
Kolkhof, Peter ;
Nowack, Christina ;
Gebel, Martin ;
Ruilope, Luis M. ;
Bakris, George L. .
EUROPEAN HEART JOURNAL, 2022, 43 (06) :474-+
[3]   Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes [J].
Bakris, George L. ;
Agarwal, Rajiv ;
Anker, Stefan D. ;
Pitt, Bertram ;
Ruilope, Luis M. ;
Rossing, Peter ;
Kolkhof, Peter ;
Nowack, Christina ;
Schloemer, Patrick ;
Joseph, Amer ;
Filippatos, Gerasimos .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23) :2219-2229
[4]  
Diabetes, 2019, Therapeutic Guidelines
[5]   Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes [J].
Pitt, Bertram ;
Filippatos, Gerasimos ;
Agarwal, Rajiv ;
Anker, Stefan D. ;
Bakris, George L. ;
Rossing, Peter ;
Joseph, Amer ;
Kolkhof, Peter ;
Nowack, Christina ;
Schloemer, Patrick ;
Ruilope, Luis M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24) :2252-2263
[6]   Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use [J].
Rossing, Peter ;
Agarwal, Rajiv ;
Anker, Stefan D. ;
Filippatos, Gerasimos ;
Pitt, Bertram ;
Ruilope, Luis M. ;
Fonseca, Vivian ;
Umpierrez, Guillermo E. ;
Caramori, Maria Luiza ;
Joseph, Amer ;
Lambelet, Marc ;
Lawatscheck, Robert ;
Bakris, George L. .
DIABETES OBESITY & METABOLISM, 2023, 25 (02) :407-416
[7]   Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis [J].
Rossing, Peter ;
Anker, Stefan D. ;
Filippatos, Gerasimos ;
Pitt, Bertram ;
Ruilope, Luis M. ;
Birkenfeld, Andreas L. ;
McGill, Janet B. ;
Rosas, Sylvia E. ;
Joseph, Amer ;
Gebel, Martin ;
Roberts, Luke ;
Scheerer, Markus F. ;
Bakris, George L. ;
Agarwal, Rajiv .
DIABETES CARE, 2022, 45 (12) :2991-2998
[8]   Therapeutic perspective: evolving evidence of nonsteroidal mineralocorticoid receptor antagonists in diabetic kidney disease [J].
Yao, Lan ;
Liang, Xianhui ;
Wang, Pei .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2023, 324 (06) :E531-E541